Artigos com autorizações de acesso público - Jeffrey M RosenSaiba mais
2 artigos não disponíveis publicamente
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis
HC Lo, Z Xu, IS Kim, B Pingel, S Aguirre, S Kodali, J Liu, W Zhang, ...
Nature Cancer 1 (7), 709-722, 2020
Autorizações: US Department of Defense, US National Institutes of Health, Cancer …
A novel technology for free flap monitoring: pilot study of a wireless, biodegradable sensor
H Oda, L Beker, Y Kaizawa, A Franklin, JG Min, J Leyden, Z Wang, ...
Journal of Reconstructive Microsurgery 36 (03), 182-190, 2020
Autorizações: US Department of Veterans Affairs
117 artigos disponíveis publicamente
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
X Li, MT Lewis, J Huang, C Gutierrez, CK Osborne, MF Wu, ...
Journal of the National Cancer Institute 100 (9), 672-679, 2008
Autorizações: US National Institutes of Health
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ...
Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009
Autorizações: US National Institutes of Health, Cancer Research UK
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
JH Taube, JI Herschkowitz, K Komurov, AY Zhou, S Gupta, J Yang, ...
Proceedings of the National Academy of Sciences 107 (35), 15449-15454, 2010
Autorizações: US National Institutes of Health
The increasing complexity of the cancer stem cell paradigm
JM Rosen, CT Jordan
science 324 (5935), 1670-1673, 2009
Autorizações: US National Institutes of Health
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
KL Meerbrey, G Hu, JD Kessler, K Roarty, MZ Li, JE Fang, JI Herschkowitz, ...
Proceedings of the National Academy of Sciences 108 (9), 3665-3670, 2011
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer
M Zhang, F Behbod, RL Atkinson, MD Landis, F Kittrell, D Edwards, ...
Cancer research 68 (12), 4674-4682, 2008
Autorizações: US National Institutes of Health
The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells
H Wang, C Yu, X Gao, T Welte, AM Muscarella, L Tian, H Zhao, Z Zhao, ...
Cancer cell 27 (2), 193-210, 2015
Autorizações: US National Institutes of Health
FOXC2 expression links epithelial–mesenchymal transition and stem cell properties in breast cancer
BG Hollier, AA Tinnirello, SJ Werden, KW Evans, JH Taube, TR Sarkar, ...
Cancer research 73 (6), 1981-1992, 2013
Autorizações: US National Institutes of Health
Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer
CJ Creighton, JC Chang, JM Rosen
Journal of mammary gland biology and neoplasia 15, 253-260, 2010
Autorizações: US National Institutes of Health
Metastasis organotropism: redefining the congenial soil
Y Gao, I Bado, H Wang, W Zhang, JM Rosen, XHF Zhang
Developmental cell 49 (3), 375-391, 2019
Autorizações: US Department of Defense, US National Institutes of Health
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
IS Kim, Y Gao, T Welte, H Wang, J Liu, M Janghorban, K Sheng, Y Niu, ...
Nature cell biology 21 (9), 1113-1126, 2019
Autorizações: US Department of Defense, US National Institutes of Health, Susan G. Komen
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ...
Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012
Autorizações: US National Institutes of Health
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
F Behbod, FS Kittrell, H LaMarca, D Edwards, S Kerbawy, JC Heestand, ...
Breast cancer research 11, 1-11, 2009
Autorizações: US National Institutes of Health
Selective targeting of radiation-resistant tumor-initiating cells
M Zhang, RL Atkinson, JM Rosen
Proceedings of the National Academy of Sciences 107 (8), 3522-3527, 2010
Autorizações: US National Institutes of Health
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
AD Pfefferle, JI Herschkowitz, J Usary, JC Harrell, BT Spike, JR Adams, ...
Genome biology 14, 1-16, 2013
Autorizações: US National Institutes of Health
Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy
RL Atkinson, M Zhang, P Diagaradjane, S Peddibhotla, A Contreras, ...
Science translational medicine 2 (55), 55ra79-55ra79, 2010
Autorizações: US National Institutes of Health
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
T Welte, IS Kim, L Tian, X Gao, H Wang, J Li, XB Holdman, ...
Nature cell biology 18 (6), 632-644, 2016
Autorizações: US National Institutes of Health, Susan G. Komen
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
NA Zhao, J Cao, L Xu, Q Tang, LE Dobrolecki, X Lv, M Talukdar, Y Lu, ...
The Journal of clinical investigation 128 (4), 1283-1299, 2018
Autorizações: US National Institutes of Health, Susan G. Komen
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador